GENDELL JEFFREY L
Q2 2021 13F-HR Holdings
Net value change ($000)
+190,880
(20.4%)
New positions
11
Sold out positions
7
Turnover %
14.3%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q1 2021
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| CLF | 73,616 | 104.6% |
| THO | 46,844 | NEW |
| X | 25,170 | NEW |
| KRE | 13,085 | 772.0% |
| AMR | 9,775 | 86.6% |
| IESC | 9,590 | 1.7% |
| WFG | 9,003 | NEW |
| MT | 8,930 | NEW |
| CWH | 7,737 | 51.3% |
| BAC | 7,681 | 193.7% |
Top Reduces (Value $000, Stocks/ETFs)
| IWM | -44,189 | -100.0% |
| PARAV | -7,668 | -100.0% |
| PATK | -4,521 | -39.5% |
| AVDL | -3,779 | -21.6% |
| Cano Health, Inc. | -3,083 | -100.0% |
| MPB | -2,399 | -100.0% |
| SEELOS THERAPEUTICS, INC. | -1,513 | -24.7% |
| LCII | -1,137 | -17.3% |
| Danimer Scientific, Inc. | -755 | -100.0% |
| OSG | -200 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
3,056
(0.3% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|